IVX.AX
Price:
$0.26
Market Cap:
$18.16M
Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genit...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2010-02-14
Stock Exchange
ASX
Ticker
IVX.AX
According to Invion Limited’s latest financial reports and current stock price. The company's current ROE is -34.85%. This represents a change of 198.79% compared to the average of -11.67% of the last 4 quarters.
The mean historical ROE of Invion Limited over the last ten years is -48.54%. The current -34.85% ROE has changed -28.19% with respect to the historical average. Over the past ten years (40 quarters), IVX.AX's ROE was at its highest in in the June 2011 quarter at 159.63%. The ROE was at its lowest in in the June 2017 quarter at -130.27%.
Average
-48.54%
Median
-34.97%
Minimum
-190.10%
Maximum
-8.78%
Discovering the peaks and valleys of Invion Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 344.06%
Maximum Annual ROE = -8.78%
Minimum Annual Increase = -78.65%
Minimum Annual ROE = -190.10%
Year | ROE | Change |
---|---|---|
2024 | -38.98% | 344.06% |
2023 | -8.78% | -23.32% |
2022 | -11.45% | -63.02% |
2021 | -30.96% | 76.34% |
2020 | -17.55% | -62.38% |
2019 | -46.66% | 298.15% |
2018 | -11.72% | -78.65% |
2017 | -54.89% | -26.08% |
2016 | -74.27% | -60.93% |
2015 | -190.10% | 180.54% |
The current ROE of Invion Limited (IVX.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-19.74%
5-year avg
-21.54%
10-year avg
-48.54%
Invion Limited’s ROE is greater than Patrys Limited (-83.38%), greater than Orthocell Limited (-214.01%), greater than Immuron Limited (-45.89%), greater than Living Cell Technologies Limited (-54.06%), less than DataDot Technology Limited (0.78%),
Company | ROE | Market cap |
---|---|---|
-83.38% | $6.17M | |
-214.01% | $340.38M | |
-45.89% | $18.79M | |
-54.06% | $24.53M | |
0.78% | $4.84M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Invion Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Invion Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Invion Limited's ROE?
How is the ROE calculated for Invion Limited (IVX.AX)?
What is the highest ROE for Invion Limited (IVX.AX)?
What is the 3-year average ROE for Invion Limited (IVX.AX)?
What is the 5-year average ROE for Invion Limited (IVX.AX)?
How does the current ROE for Invion Limited (IVX.AX) compare to its historical average?